Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 28:14:1200534.
doi: 10.3389/fneur.2023.1200534. eCollection 2023.

Safety and efficacy of remote ischemic conditioning in adult moyamoya disease patients undergoing revascularization surgery: a pilot study

Affiliations

Safety and efficacy of remote ischemic conditioning in adult moyamoya disease patients undergoing revascularization surgery: a pilot study

Heng Yang et al. Front Neurol. .

Abstract

Background and purpose: Revascularization surgery for patients with moyamoya disease (MMD) is very complicated and has a high rate of postoperative complications. This pilot study aimed to prove the safety and efficacy of remote ischemic conditioning (RIC) in adult MMD patients undergoing revascularization surgery.

Methods: A total of 44 patients with MMD were enrolled in this single-center, open-label, prospective, parallel randomized study, including 22 patients assigned to the sham group and 22 patients assigned to the RIC group. The primary outcome was the incidence of major neurologic complications during the perioperative period. Secondary outcomes were the modified Rankin Scale (mRS) score at discharge, at 90 days post-operation, and at 1 year after the operation. The outcome of safety was the incidence of adverse events associated with RIC. Blood samples were obtained to monitor the serum concentrations of cytokines (VEGF, IL-6).

Results: No subjects experienced adverse events during RIC intervention, and all patients could tolerate the RIC intervention in the perioperative period. The incidence of major neurologic complications was significantly lower in the RIC group compared with the control group (18.2% vs. 54.5%, P = 0.027). The mRS score at discharge in the RIC group was also lower than the control group (0.86 ± 0.99 vs. 1.18 ± 1.22, P = 0.035). In addition, the serum IL-6 level increased significantly at 7 days after bypass surgery in the control group and the serum level of VEGF at 7 days post-operation in the RIC group.

Conclusion: In conclusion, our study demonstrated the neuroprotective effect of RIC by reducing perioperative complications and improving cerebral blood flow in adult MMD patients undergoing revascularization surgery. Thus, RIC seems to be a potential treatment method for MMD.

Clinical trial registration: ClinicalTrials.gov, identifier: NCT05860946.

Keywords: complications; modified Rankin Scale (mRS); moyamoya disease; remote ischemic conditioning; revascularization surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of patient enrollment.
Figure 2
Figure 2
Cerebral blood flow at the baseline and 7 days after operation. Arterial spin labeling (ASL) images of the patient in both the control and RIC groups demonstrated remarkable perfusion improvement after bypass surgery, especially in the RIC group.
Figure 3
Figure 3
Changes in serum cytokines for MMD patients undergoing revascularization surgery after RIC. The serum IL-6 level increased significantly at 7 days after revascularization surgery in the control group but was not significantly different between pre- and post-operation in the RIC group (A). RIC could also significantly elevate the level of VEGF at 7 days post-operation in the RIC group, but the change of the VEGF level had no obvious difference after operation in the control group (B) (*P < 0.05, **P < 0.01 vs. baseline).

Similar articles

Cited by

References

    1. Ishikawa T, Kamiyama H, Kuroda S, Yasuda H, Nakayama N, Takizawa K. Simultaneous superficial temporal artery to middle cerebral or anterior cerebral artery bypass with pan-synangiosis for Moyamoya disease covering both anterior and middle cerebral artery territories. Neurol Med Chir. (2006) 46:462–8. 10.2176/nmc.46.462 - DOI - PubMed
    1. Ni W, Xu F, Xu B, Liao Y, Gu Y, Song D. Disappearance of aneurysms associated with moyamoya disease after STA-MCA anastomosis with encephaloduro myosynangiosis. J Clin Neurosci. (2012) 19:485–7. 10.1016/j.jocn.2011.05.036 - DOI - PubMed
    1. Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, et al. . Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg. (2014) 121:1048–55. 10.3171/2014.7.JNS132434 - DOI - PubMed
    1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. (1986) 74:1124–36. 10.1161/01.CIR.74.5.1124 - DOI - PubMed
    1. Cheung MMH, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. . Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. (2006) 47:2277–82. 10.1016/j.jacc.2006.01.066 - DOI - PubMed

Associated data